• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[慢性肝病患者应用镇静剂的临床问题(作者译)]

[Clinical problems in the application of sedatives in patients with chronic liver disease (author's transl)].

作者信息

Becker K

出版信息

Z Gastroenterol. 1977 Jun;15(6):356-61.

PMID:888484
Abstract

In these introductory remarks the application of sedatives in patients with chronic liver diseases is discussed. Sedatives, for example, are used in agitated alcoholics with liver damage, as premedication before endoscopical examinations (emergency endoscopy for hemorrhage from the upper G.i.-tract, peritoneoscopy), and operations necessary for the treatment of typical complications of the liver disease (shunt-op. for portal hypertension). In all these situations the metabolism and pharmaco-kinetics of sedatives may be influenced by the liver disease in a non-predictable way. Generally, an enhanced, enforced and prolonged effect can be assumed. Long acting barbiturates are recommended for a long period treatment, diazepam in reduced doses is used as premedication for endoscopical examination. Opiates should be avoided.

摘要

在这些引言性评论中,讨论了镇静剂在慢性肝病患者中的应用。例如,镇静剂用于患有肝损伤的躁动酗酒者,作为内镜检查(上消化道出血的急诊内镜检查、腹腔镜检查)以及治疗肝病典型并发症所需手术(门静脉高压分流术)前的术前用药。在所有这些情况下,肝病可能以不可预测的方式影响镇静剂的代谢和药代动力学。一般来说,可以假定会有增强、强化和延长的效果。长效巴比妥类药物推荐用于长期治疗,小剂量地西泮用作内镜检查的术前用药。应避免使用阿片类药物。

相似文献

1
[Clinical problems in the application of sedatives in patients with chronic liver disease (author's transl)].[慢性肝病患者应用镇静剂的临床问题(作者译)]
Z Gastroenterol. 1977 Jun;15(6):356-61.
2
The disposition and effects of sedatives and analgesics in liver disease.肝病中镇静剂和镇痛药的处置与作用
Annu Rev Med. 1978;29:205-18. doi: 10.1146/annurev.me.29.020178.001225.
3
[Hypnotics and sedatives in liver diseases (summary of session 4)].[肝病中的催眠药和镇静剂(第4节总结)]
Z Gastroenterol Verh. 1976(12):203-20.
4
[Sedatives and liver diseases].
Minerva Med. 1973;64(49):2619-21.
5
The effect of parenchymal liver disease on the disposition and elimination of sedatives and analgesics.实质性肝脏疾病对镇静剂和镇痛药的处置及消除的影响。
Med Clin North Am. 1975 Jul;59(4):887-96. doi: 10.1016/s0025-7125(16)31987-3.
6
[Clinical pharmacology of narcotics and sedatives].
Z Allgemeinmed. 1971 Dec 20;47(35):1846-52.
7
[Drug therapy in liver diseases: problems in intensive care].[肝脏疾病的药物治疗:重症监护中的问题]
Schweiz Med Wochenschr. 1986 Apr 26;116(17):549-52.
8
The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.肝脏和肾脏功能障碍对危重症患者镇静剂和镇痛药药代动力学的影响。
Crit Care Nurs Clin North Am. 2005 Sep;17(3):245-50. doi: 10.1016/j.ccell.2005.04.007.
9
Major drug interactions: effect of liver disease, alcohol, and malnutrition.
Annu Rev Med. 1982;33:113-49. doi: 10.1146/annurev.me.33.020182.000553.
10
[Metabolism of hypnotic and sedative drugs in cholestasis (author's transl)].
Z Gastroenterol. 1977 Jun;15(6):373-7.